Ning Chen — 8 Patents at Amgen

Issued Patents 2021

Showing 1–8 of 8 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11124780	Genetically engineered bacterium used for producing uridine with high-yield	Xixian Xie, Heyun Wu, Guoliang Li, Qiang Li, Xiaoguang Fan +4 more	2021-09-21
11096939	KRAS G12C inhibitors and methods of using the same	Shon Booker, John Gordon Allen, Brian Alan LANMAN, Ryan Wurz, Victor J. Cee +3 more	2021-08-24	$214,522,000
11090304	KRAS G12C inhibitors and methods of using the same	John Gordon Allen, Jennifer R. Allen, Ana Elena Minatti, Qiufen Xue, Ryan Wurz +22 more	2021-08-17	$335,995,000
11046680	Heteroaryl-substituted triazoles as APJ receptor agonists	Xiaoqi Chen, Yinhong Chen, Alan C. Cheng, Richard V. Connors, Jeffrey Deignan +24 more	2021-06-29	$263,699,000
11045484	KRAS G12C inhibitors and methods of using the same	Ryan Wurz, Victor J. Cee, Albert Amegadzie, Brian Alan LANMAN, Michael D. Bartberger	2021-06-29	$263,699,000
11021493	1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use	Jennifer R. Allen, Matthew P. Bourbeau, James Brown, Michael J. Frohn, Zice Fu +6 more	2021-06-01	$258,451,000
10947223	Substituted oxazines as beta-secretase inhibitors	Jennifer R. Allen, Matthew P. Bourbeau, Michael J. Frohn, Paul E. Harrington, Qingyian Liu +1 more	2021-03-16	$1,023,364,000
10906890	Triazole phenyl compounds as agonists of the APJ receptor	Yinhong Chen, Mikkel V. Debenedetto, Paul John Dransfield, James S. Harvey, Julie Anne Heath +9 more	2021-02-02	$295,872,000